Navigating the thyroid-gynecologic interplay: a systematic review and meta-analysis
1
조회
0
다운로드
0
인용
0
참고문헌
키워드
초록
Thyroid disorders are considered to be linked to various health issues, including gynecologic cancers. Studying this association is crucial in clinical practice. This approach was applied through searches in Scopus, WOS, PubMed, and Google Scholar. A Preferred Reporting Items for Systematic Reviews and Meta-Analyses checklist was followed. The quality assessment was checked. The meta-analyses were performed using R-4.3.2 (R Core Team, Vienna, Austria) and SPSS version 28 (SPSS Inc., Armonk, NY, USA). The results demonstrated that 19 studies investigated the association between thyroid disorders and gynecologic cancers in adult females. The studies were categorized into two groups: group 1 examined thyroid status in various gynecologic cancers, while group 2 comprised casecontrol studies examining gynecologic cancer incidence in females with thyroid disorders compared to control. Among females with gynecologic cancers, 13% (95% confidence interval [CI], 10-17%) had hypothyroidism. When comparing hypothyroidism and hyperthyroidism across studies, the overall percentage for hypothyroidism was 14% (95% CI, 9-22%), while for hyperthyroidism, it was 3% (95% CI, 2-5%). The odds ratio for hypothyroidism in females with uterine cancer was 2.65 (P<0.05). Additionally, hypothyroidism showed a significant risk ratio of 1.3 (P<0.05) for different gynecologic cancers. However, hyperthyroidism was significantly associated with increased ovarian cancer mortality (risk ratio [RR], 2.14; P=0.03); conversely, hypothyroidism showed no significant relationship (RR, 1.35; P=0.26). The findings concluded that hypothyroidism is significantly associated with various gynecologic cancers, suggesting a potential role in its pathogenesis. Conversely, hyperthyroidism is linked to an increased risk of ovarian cancer mortality. Further research is needed to clarify whether hyperthyroidism predisposes females to ovarian cancer.
Abstract
Thyroid disorders are considered to be linked to various health issues, including gynecologic cancers. Studying this association is crucial in clinical practice. This approach was applied through searches in Scopus, WOS, PubMed, and Google Scholar. A Preferred Reporting Items for Systematic Reviews and Meta-Analyses checklist was followed. The quality assessment was checked. The meta-analyses were performed using R-4.3.2 (R Core Team, Vienna, Austria) and SPSS version 28 (SPSS Inc., Armonk, NY, USA). The results demonstrated that 19 studies investigated the association between thyroid disorders and gynecologic cancers in adult females. The studies were categorized into two groups: group 1 examined thyroid status in various gynecologic cancers, while group 2 comprised casecontrol studies examining gynecologic cancer incidence in females with thyroid disorders compared to control. Among females with gynecologic cancers, 13% (95% confidence interval [CI], 10-17%) had hypothyroidism. When comparing hypothyroidism and hyperthyroidism across studies, the overall percentage for hypothyroidism was 14% (95% CI, 9-22%), while for hyperthyroidism, it was 3% (95% CI, 2-5%). The odds ratio for hypothyroidism in females with uterine cancer was 2.65 (P<0.05). Additionally, hypothyroidism showed a significant risk ratio of 1.3 (P<0.05) for different gynecologic cancers. However, hyperthyroidism was significantly associated with increased ovarian cancer mortality (risk ratio [RR], 2.14; P=0.03); conversely, hypothyroidism showed no significant relationship (RR, 1.35; P=0.26). The findings concluded that hypothyroidism is significantly associated with various gynecologic cancers, suggesting a potential role in its pathogenesis. Conversely, hyperthyroidism is linked to an increased risk of ovarian cancer mortality. Further research is needed to clarify whether hyperthyroidism predisposes females to ovarian cancer.
참고문헌 (27)
- "Physiology, thyroid hormone" (2023)[URL]
- Tran TV, "Thyroid dysfunction and cancer incidence : a systematic review and meta-analysis", Endocr Relat Cancer, 27, pp.245~259 (2020)
- Leung JH, "Hypothyroidism and hyperthyroidism related to gynecologic cancers : a nationwide population-based cohort study", Sci Rep, 14, pp.1892~ (2024)
- Ha HI, "The incidence and survival of cervical, ovarian, and endometrial cancer in Korea, 1999-2017 : Korea Central Cancer Registry", Obstet Gynecol Sci, 64, pp.444~453 (2021)
- Almadrones-Cassidy LA, "Gynecologic cancers" (2010), Oncology Nursing Society
- Lee DY, "Associations between metabolic syndrome and gynecologic cancer", Obstet Gynecol Sci, 63, pp.215~224 (2020)
- Kang JH, "A large cohort study of hypothyroidism and hyperthyroidism in relation to gynecologic cancers", Obstet Gynecol Int, 2013, pp.743721~ (2013)
- Liao Y, "Correlation of hypothyroidism and endometrial carcinoma", Cancer Research on Prevention and Treatment, 46, pp.452~455 (2019)
- Elgebaly MM, "Hypothyroidism affect progression and worse outcomes of breast cancer but not ovarian cancer", J Immunoassay Immunochem, 43, pp.288~298 (2022)
- Shi XZ, "Relationship between breast cancer and levels of serum thyroid hormones and antibodies : a meta-analysis", Asian Pac J Cancer Prev, 15, pp.6643~6647 (2014)
- Du D, "The relationship between thyroiditis and polycystic ovary syndrome : a meta-analysis", Int J Clin Exp Med, 6, pp.880~889 (2013)
- Stang A, "Critical evaluation of the Newcastle-Ottawa scale for the assessment of the quality of nonrandomized studies in meta-analyses", Eur J Epidemiol, 25, pp.603~605 (2010)
- Aga SS, "Detailed demographics and the prevalence of comorbidities in ovarian cancer patients in Western Region of Saudi Arabia", J Nat Sci Med, 5, pp.254~261 (2022)
- Díez JJ, "Malignant neoplasms in people with hypothyroidism in Spain : a population-based analysis", PLoS One, 17, pp.e0275568~ (2022)
- Li S, "Relationship between thyroid disorders and uterine fibroids among reproductive-age women", Endocr J, 68, pp.211~219 (2021)
- Jha S, "Rate of premalignant and malignant endometrial lesion in"low-risk"premenopausal women with abnormal uterine bleeding undergoing endometrial biopsy", Obstet Gynecol Sci, 64, pp.517~523 (2021)
- Vilardo N, "Thyroid function and survival outcomes in women with uterine cancer", Gynecologic Oncology, 162, pp.S309~ (2021)
- Almehmadi M, "Assessment of thyroid gland function by evaluating of TSH, FT3 and FT4 hormones in untreated cancer patients", J Adv Pharm Educ Res, 10, pp.37~42 (2020)
- Journy NMY, "Hyperthyroidism, hypothyroidism, and cause-specific mortality in a large cohort of women", Thyroid, 27, pp.1001~1010 (2017)
- Kurnit KC, "Increased prevalence of comorbid conditions in women with uterine cancer", Gynecol Oncol, 138, pp.731~734 (2015)
- Ott J, "Overt hypothyroidism is associated with the presence of uterine leiomyoma : a retrospective analysis", Eur J Obstet Gynecol Reprod Biol, 177, pp.19~22 (2014)
- Soleymani E, "Histopathological findings of endometrial specimens in abnormal uterine bleeding", Arch Gynecol Obstet, 289, pp.845~849 (2014)
- Seebacher V, "Does thyroid-stimulating hormone influence the prognosis of patients with endometrial cancer? A multicentre trial", Br J Cancer, 109, pp.215~218 (2013)
- Chen YK, "Cancer risk in patients with Hashimoto’s thyroiditis : a nationwide cohort study", Br J Cancer, 109, pp.2496~2501 (2013)
- Chen YK, "Cancer risk in patients with Graves’ disease : a nationwide cohort study", Thyroid, 23, pp.879~884 (2013)
- Brinton LA, "Relationships of uterine and ovarian tumors to pre-existing chronic conditions", Gynecol Oncol, 107, pp.487~494 (2007)
- Ness RB, "Factors related to inflammation of the ovarian epithelium and risk of ovarian cancer", Epidemiology, 11, pp.111~117 (2000)